HUS1500060I1 - A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina - Google Patents
A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcinaInfo
- Publication number
- HUS1500060I1 HUS1500060I1 HUS1500060C HUS1500060C HUS1500060I1 HU S1500060 I1 HUS1500060 I1 HU S1500060I1 HU S1500060 C HUS1500060 C HU S1500060C HU S1500060 C HUS1500060 C HU S1500060C HU S1500060 I1 HUS1500060 I1 HU S1500060I1
- Authority
- HU
- Hungary
- Prior art keywords
- hpv
- hpv18
- type selected
- vaccine against
- another
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0413510.9A GB0413510D0 (en) | 2004-06-16 | 2004-06-16 | Vaccine |
EP05757953A EP1758609B1 (en) | 2004-06-16 | 2005-06-14 | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUS1500060I1 true HUS1500060I1 (hu) | 2017-10-30 |
Family
ID=32750044
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUS1500060C HUS1500060I1 (hu) | 2004-06-16 | 2015-12-01 | A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina |
HUS1500059C HUS1500059I1 (hu) | 2004-06-16 | 2015-12-01 | A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina |
HUS1500061C HUS1500061I1 (hu) | 2004-06-16 | 2015-12-01 | A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUS1500059C HUS1500059I1 (hu) | 2004-06-16 | 2015-12-01 | A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina |
HUS1500061C HUS1500061I1 (hu) | 2004-06-16 | 2015-12-01 | A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina |
Country Status (15)
Country | Link |
---|---|
JP (1) | JP2012102132A (zh) |
KR (1) | KR101359943B1 (zh) |
CN (1) | CN1976718B (zh) |
CY (1) | CY1113830T1 (zh) |
DK (1) | DK1758609T3 (zh) |
ES (1) | ES2394448T3 (zh) |
GB (1) | GB0413510D0 (zh) |
HR (1) | HRP20120930T1 (zh) |
HU (3) | HUS1500060I1 (zh) |
LT (1) | LTC1758609I2 (zh) |
NL (3) | NL300771I2 (zh) |
PT (1) | PT1758609E (zh) |
SI (1) | SI1758609T1 (zh) |
TW (1) | TW200612983A (zh) |
ZA (1) | ZA200610057B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102458440A (zh) * | 2009-04-10 | 2012-05-16 | 约翰·霍普金斯大学 | 作为广谱人类乳头状瘤病毒(hpv)疫苗的乳头状瘤病毒样颗粒(vlp) |
MX2013000584A (es) * | 2010-07-15 | 2013-09-26 | British Columbia Cancer Agency | Composiciones de antigeno e7 de virus de papiloma humano y usos de las mismas. |
CN107188966B (zh) | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | 一种乳头瘤病毒嵌合蛋白及其用途 |
CN114539365B (zh) * | 2020-11-26 | 2023-12-01 | 中国医学科学院基础医学研究所 | 一种改造的人乳头瘤病毒52型l1蛋白及其用途 |
CN114716560B (zh) | 2021-01-04 | 2024-02-02 | 中国医学科学院基础医学研究所 | 一种人乳头瘤病毒18型嵌合蛋白及其用途 |
CN114716561B (zh) | 2021-01-04 | 2024-03-12 | 中国医学科学院基础医学研究所 | 一种人乳头瘤病毒31型嵌合蛋白及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
GB9921147D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
GB0110431D0 (en) * | 2001-04-27 | 2001-06-20 | Glaxosmithkline Biolog Sa | Novel compounds |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206359D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
-
2004
- 2004-06-16 GB GBGB0413510.9A patent/GB0413510D0/en not_active Ceased
-
2005
- 2005-06-14 ES ES05757953T patent/ES2394448T3/es active Active
- 2005-06-14 KR KR1020127027786A patent/KR101359943B1/ko active IP Right Grant
- 2005-06-14 DK DK05757953.4T patent/DK1758609T3/da active
- 2005-06-14 TW TW094119691A patent/TW200612983A/zh unknown
- 2005-06-14 CN CN2005800195155A patent/CN1976718B/zh active Active
- 2005-06-14 PT PT57579534T patent/PT1758609E/pt unknown
- 2005-06-14 SI SI200531633T patent/SI1758609T1/sl unknown
-
2006
- 2006-11-30 ZA ZA200610057A patent/ZA200610057B/en unknown
-
2012
- 2012-01-06 JP JP2012001102A patent/JP2012102132A/ja active Pending
- 2012-11-16 HR HRP20120930TT patent/HRP20120930T1/hr unknown
- 2012-12-11 CY CY20121101211T patent/CY1113830T1/el unknown
-
2015
- 2015-11-30 NL NL300771C patent/NL300771I2/nl unknown
- 2015-11-30 NL NL300774C patent/NL300774I1/nl unknown
- 2015-11-30 NL NL300773C patent/NL300773I2/nl unknown
- 2015-12-01 HU HUS1500060C patent/HUS1500060I1/hu unknown
- 2015-12-01 HU HUS1500059C patent/HUS1500059I1/hu unknown
- 2015-12-01 HU HUS1500061C patent/HUS1500061I1/hu unknown
- 2015-12-07 LT LTPA2015046C patent/LTC1758609I2/lt unknown
Also Published As
Publication number | Publication date |
---|---|
ES2394448T3 (es) | 2013-01-31 |
CN1976718A (zh) | 2007-06-06 |
NL300771I1 (zh) | 2015-12-29 |
ZA200610057B (en) | 2008-02-27 |
CN1976718B (zh) | 2012-10-10 |
DK1758609T3 (da) | 2012-12-10 |
PT1758609E (pt) | 2012-12-21 |
NL300771I2 (zh) | 2015-12-29 |
HUS1500061I1 (hu) | 2016-01-28 |
GB0413510D0 (en) | 2004-07-21 |
NL300774I2 (zh) | 2015-12-29 |
HRP20120930T1 (hr) | 2012-12-31 |
NL300773I1 (zh) | 2015-12-29 |
JP2012102132A (ja) | 2012-05-31 |
CY1113830T1 (el) | 2016-06-22 |
KR20120123617A (ko) | 2012-11-08 |
HUS1500059I1 (hu) | 2017-10-30 |
KR101359943B1 (ko) | 2014-02-10 |
LTC1758609I2 (lt) | 2017-05-10 |
NL300774I1 (zh) | 2015-12-29 |
TW200612983A (en) | 2006-05-01 |
SI1758609T1 (sl) | 2013-01-31 |
NL300773I2 (zh) | 2015-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1500060I1 (hu) | A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina | |
HK1085378A1 (en) | Use of hpv16 and hpv18 as vaccine against one or more of oncogenic hpv type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 | |
IL179138A0 (en) | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31,45, or 52 | |
IL190775A (en) | Influenza virus-like particles, vaccines containing them and their uses | |
EP1784163A4 (en) | NANOEMULSION, USE THEREOF AND PROCESS FOR PREPARING THE SAME | |
IL178160A0 (en) | Cellular permissivity factor for viruses, and uses thereof | |
AU2003271215A8 (en) | Vector for anti-hpv vaccine and transformed microorganism by the vector | |
IL181569A0 (en) | Biotinylated hexadecasaccharides, preparation and use thereof | |
AU2005279590A1 (en) | Vaccine composition against hepatitis C virus | |
AU2003290012A1 (en) | L2-peptide of the human papillomavirus associated with virus-like particles | |
USD502767S1 (en) | Heater fan | |
SI1572233T1 (sl) | Uporaba HPV16 in HPV18 kot cepivo proti enemu ali več onkogenih HPV tipa 31,33,35,39,45,51,52,56,58,59,66,68 | |
AU2002236065A1 (en) | Papillomavirus vaccines | |
CY2015048I1 (el) | Εμβολιο εναντι hpv16 και hpv18 και τουλαχιστον ενος αλλου τυπου hpv ο οποιος επιλεγεται απο hpv 31,45 ή 52 | |
Moktan | Book of oral recitations and moral teachings | |
GB0508726D0 (en) | Polypeptide, vaccine and use thereof | |
AU2001266534A1 (en) | Papillomavirus vaccine | |
Kerzel et al. | Beiträge zur 46. Tagung experimentell arbeitender Psychologen | |
Rowe | It's the overall amount, silly | |
Bullis | Residents and Faculty, Eastman Dental Center, 2004 | |
Hussain | Boldface | |
AU2005903972A0 (en) | Viral resistant mutants and uses thereof | |
AU2003292136A1 (en) | Vaccines against viruses with cationic substances as adjuvants | |
AU2003904499A0 (en) | Coronavirus vaccines, therapeutics and diagnostics | |
GB0100288D0 (en) | Virus strains |